Authors: Kerbusch, T de Kraker, J Keizer, HJ van Putten, JWG Groen, HJM Jansen, RLH Schellens, JHM Beijnen, JH

Citation: T. Kerbusch et al., Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites, CLIN PHARMA, 40(1), 2001, pp. 41-62

Authors: Kerbusch, T Jansen, RLH Mathot, RAA Huitema, ADR Jansen, M van Rijswijk, REN Beijnen, JH

Citation: T. Kerbusch et al., Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin, CLIN PHARM, 70(2), 2001, pp. 132-141

Authors: Jager, JJ Jansen, RLH Arends, JW Joosten-Achjanie, S Volovics, L Schouten, LJ De Jong, JMA Meyenfeldt, MFV Blijham, GH

Citation: Jj. Jager et al., Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer, ANTICANC R, 20(2B), 2000, pp. 1269-1275

Authors: van Herpen, CML Jansen, RLH Kruit, WHJ Hoekman, K Groenewegen, G Osanto, S De Mulder, PHM

Citation: Cml. Van Herpen et al., Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracilfor progressive metastatic renal cell carcinoma: a multicenter phase II study, BR J CANC, 82(4), 2000, pp. 772-776

Authors: Peters, FPJ van de Beek, C Bot, FJ Jansen, RLH

Citation: Fpj. Peters et al., Xanthogranulomatous pyelonephritis - A pseudo-neoplastic disease, ACTA ONCOL, 38(2), 1999, pp. 269-270

Authors: Jansen, RLH Joosten-Achjanie, SR Volovics, A Arends, JW Hupperets, PSGJ Hillen, HFP Schouten, HC

Citation: Rlh. Jansen et al., Relevance of the expression of Bcl-2 in combination with p53 as a prognostic factor in breast cancer, ANTICANC R, 18(6A), 1998, pp. 4455-4462